Minshan Chen
Impact in
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 2%
Papers in
- Hepatology 122
- Hepatocellular Carcinoma Treatment and Prognosis 119
- Oncology 32
- Inflammatory Biomarkers in Disease Prognosis 11
- Cancer Immunotherapy and Biomarkers 10
- Co-authors
- Yaojun Zhang (104 shared papers)Li Xu (61 shared papers)Masatoshi Kudo (7 shared papers)Rong Guo (25 shared papers)Lucinda Orsini (3 shared papers)Lewis R. Roberts (2 shared papers)Pei‐Jer Chen (2 shared papers)Morris Sherman (2 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)International Journal of Surgery (10 papers)Frontiers in Oncology (5 papers)Hepatology (5 papers)Frontiers in Pharmacology (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Minshan Chen
186 papers receiving 5.2k citations
Minshan Chen's Hit Papers
Peers
Comparison fields: 5 of 107
- Hepatology 2.8k
- Cancer Research 600
- Oncology 919
- Epidemiology 711
- Pathology and Forensic Medicine 371
Countries citing papers authored by Minshan Chen
This map shows the geographic impact of Minshan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minshan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minshan Chen more than expected).
Fields of papers citing papers by Minshan Chen
This network shows the impact of papers produced by Minshan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minshan Chen. The network helps show where Minshan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Minshan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 193 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global patterns of hepatocellular carcinoma management from diagnosis to death: the Hit paper breakdown → | 2015 | 919 |
| 2 | 2015 | 199 | |
| 3 | 2020 | 154 | |
| 4 | 2021 | 146 | |
| 5 | 2018 | 124 | |
| 6 | 2018 | 124 | |
| 7 | 2019 | 117 | |
| 8 | 2011 | 110 | |
| 9 | 2013 | 107 | |
| 10 | 2018 | 102 | |
| 11 | 2018 | 99 | |
| 12 | 2018 | 86 | |
| 13 | 2023 | 82 | |
| 14 | 2013 | 78 | |
| 15 | 2011 | 70 | |
| 16 | 2015 | 66 | |
| 17 | 2013 | 65 | |
| 18 | 2018 | 61 | |
| 19 | 2021 | 57 | |
| 20 | 2018 | 55 |
About Minshan Chen
Minshan Chen is a scholar working on Hepatology, Oncology, Surgery, Epidemiology and Cancer Research, having authored 193 papers that have together received 5.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (119 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers), Liver Disease Diagnosis and Treatment (19 papers), Cancer Mechanisms and Therapy (16 papers), Cancer, Lipids, and Metabolism (16 papers), Inflammatory Biomarkers in Disease Prognosis (11 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Hepatitis B Virus Studies (9 papers). The work is most often cited by research in Hepatology (2.8k citations), Cancer Research (600 citations), Oncology (919 citations), Epidemiology (711 citations) and Pathology and Forensic Medicine (371 citations). Minshan Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yaojun Zhang, Li Xu, Masatoshi Kudo, Rong Guo, Lucinda Orsini, Lewis R. Roberts, Pei‐Jer Chen, Morris Sherman, Myron Schwartz and Philip J. Johnson. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Surgery, Frontiers in Oncology, Hepatology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.